← All Sponsors

SPONSOR

HRYZ Biotech Co.

Total Trials

1

Recruiting

1

Phases

Phase 2

Conditions studied: Leiomyosarcoma Liposarcoma Synovial Sarcoma Angiosarcoma Undifferentiated Pleomorphic Sarcoma Epithelioid Sarcoma Malignant Peripheral Nerve Sheath Tumors Fibrosarcoma Pleomorphic Rhabdomyosarcoma Endometrial Stromal Sarcoma

NCT06277154 Phase 2

MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma